tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Income Statement

Compare
2,835 Followers

ADMA Biologics Income Statement

Last quarter (Q4 2024), ADMA Biologics's total revenue was $117.55M, an increase of 59.06% from the same quarter last year. In Q4, ADMA Biologics's net income was $111.90M. See ADMA Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 426.45M$ 258.21M$ 154.08M$ 80.94M$ 42.22M
Gross Profit
$ 219.55M$ 88.94M$ 35.27M$ 1.17M$ -19.07M
Operating Expenses
$ 80.57M$ 67.31M$ 74.63M$ 59.55M$ 45.84M
Depreciation and Amortization
$ 8.04M$ 8.33M$ 7.11M$ 5.50M$ 3.94M
EBITDA
$ 147.69M$ 5.12M$ -39.72M$ -53.33M$ -59.82M
Operating Income
$ 138.98M$ 21.63M$ -39.37M$ -58.37M$ -64.91M
Other Income/Expenses
$ -13.27M$ -49.87M$ -26.75M$ -13.51M$ -10.83M
Pretax Income
$ 125.71M$ -28.24M$ -65.90M$ -71.65M$ -75.75M
Net Income
$ 197.67M$ -28.24M$ -85.18M$ -84.45M$ -87.61M
Per Share Metrics
Basic EPS
$ 0.85$ -0.13$ -0.43$ -0.61$ -1.02
Diluted EPS
$ 0.81$ -0.13$ -0.43$ -0.61$ -1.02
Weighted Average Shares Outstanding
233.08M 223.98M 197.87M 139.58M 86.15M
Weighted Average Shares Outstanding (Diluted)
243.34M 223.98M 197.87M 139.58M 86.15M
Currency in USD

ADMA Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis